Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiotoxicity × Restraint, Physical × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Neoplasms 6 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Prostatic Neoplasms 4 Melanoma 4 Squamous Cell Carcinoma of Head and Neck 3 Hematologic Neoplasms 3 Glioblastoma 3 Uterine Cervical Dysplasia 2 Sarcoma 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Lymphedema 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioma 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Atypical Squamous Cells of the Cervix 2 Xeroderma Pigmentosum 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Trichothiodystrophy Syndromes 1 Tongue Neoplasms 1 Squamous Intraepithelial Lesions 1 Spinal Cord Neoplasms 1 Smoking Cessation 1 Smoking 1 Signs and Symptoms, Digestive 1 Sexual Dysfunction, Physiological 1

Interventions

Doxorubicin 15 Echocardiography 13 Exercise 8 Electrocardiography 7 Dexrazoxane 7 Cyclophosphamide 7 Trastuzumab 6 Razoxane 5 Carvedilol 5 Vincristine 4 Filgrastim 4 Radiotherapy 3 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Docetaxel 3 Cisplatin 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Tablets 2 Social Determinants of Health 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Chemotherapy, Adjuvant 2 Blood Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02571894 2018-03-07

COBC

Karolinska University Hospital

Phase NA Unknown

Breast Neoplasms, Cardiomyopathies, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡